ATE194599T1 - Cyclische nitrone, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents

Cyclische nitrone, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Info

Publication number
ATE194599T1
ATE194599T1 AT92115575T AT92115575T ATE194599T1 AT E194599 T1 ATE194599 T1 AT E194599T1 AT 92115575 T AT92115575 T AT 92115575T AT 92115575 T AT92115575 T AT 92115575T AT E194599 T1 ATE194599 T1 AT E194599T1
Authority
AT
Austria
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
cyclic nitrones
nitrones
Prior art date
Application number
AT92115575T
Other languages
German (de)
English (en)
Inventor
Albert Anthony Carr
Craig Eugene Thomas
Ronald Charles Bernotas
George Ku
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE194599T1 publication Critical patent/ATE194599T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT92115575T 1991-09-12 1992-09-11 Cyclische nitrone, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten ATE194599T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75806391A 1991-09-12 1991-09-12
US82807592A 1992-01-30 1992-01-30

Publications (1)

Publication Number Publication Date
ATE194599T1 true ATE194599T1 (de) 2000-07-15

Family

ID=27116485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92115575T ATE194599T1 (de) 1991-09-12 1992-09-11 Cyclische nitrone, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Country Status (18)

Country Link
EP (1) EP0532027B1 (enExample)
JP (1) JP3255989B2 (enExample)
KR (1) KR100232025B1 (enExample)
AR (1) AR247731A1 (enExample)
AT (1) ATE194599T1 (enExample)
AU (1) AU652662B2 (enExample)
DE (1) DE69231238T2 (enExample)
DK (1) DK0532027T3 (enExample)
ES (1) ES2149161T3 (enExample)
FI (1) FI101071B (enExample)
GR (1) GR3034551T3 (enExample)
HU (1) HU216788B (enExample)
IL (1) IL103111A (enExample)
MX (1) MX9205199A (enExample)
NO (1) NO179514C (enExample)
NZ (1) NZ244268A (enExample)
PT (1) PT532027E (enExample)
TW (1) TW257755B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ316288A (en) * 1995-09-11 2000-01-28 Hoechst Marion Roussel Inc 3,4-dihydro-isoquinoline, 4,5-3H-benzo[c]azepin-7-ol and 1H-isoindole derivatives and pharmaceutical compositions containing them
EP1288203B1 (en) * 1995-09-11 2005-04-20 Aventis Pharmaceuticals Inc. Cyclic nitrones and pharmaceutical compositions containing them
DE10303254B3 (de) * 2003-01-28 2004-09-23 Johannes-Gutenberg-Universität Mainz 3,3-Dimethyl-8-oxoisochinoline, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3044930A (en) * 1960-12-08 1962-07-17 Phillips Petroleum Co N-oxides of heterocyclic nitrogen compounds as bird and rodent repellents
ES2044829T3 (es) * 1989-10-17 1995-01-16 Oklahoma Med Res Found Metodo y composiciones para la inhibicion de alteraciones asociadas con las lesiones oxidativas de los tejidos.

Also Published As

Publication number Publication date
AU2280092A (en) 1993-03-18
NO179514B (no) 1996-07-15
EP0532027B1 (en) 2000-07-12
JPH05213870A (ja) 1993-08-24
AR247731A1 (es) 1995-03-31
FI101071B (fi) 1998-04-15
AU652662B2 (en) 1994-09-01
JP3255989B2 (ja) 2002-02-12
FI924076A0 (fi) 1992-09-11
HUT67022A (en) 1995-01-30
NO923538L (no) 1993-03-15
IL103111A (en) 1996-07-23
KR930005981A (ko) 1993-04-20
EP0532027A1 (en) 1993-03-17
HU216788B (hu) 1999-08-30
NO179514C (no) 1996-10-23
DK0532027T3 (da) 2000-10-23
MX9205199A (es) 1994-01-31
NO923538D0 (no) 1992-09-11
TW257755B (enExample) 1995-09-21
GR3034551T3 (en) 2001-01-31
NZ244268A (en) 1994-09-27
IL103111A0 (en) 1993-02-21
DE69231238D1 (de) 2000-08-17
HU9202923D0 (en) 1992-11-30
PT532027E (pt) 2000-10-31
ES2149161T3 (es) 2000-11-01
KR100232025B1 (ko) 1999-12-01
DE69231238T2 (de) 2000-12-21
FI924076L (fi) 1993-03-13

Similar Documents

Publication Publication Date Title
DE10199027I2 (de) Fluorcytidinderivate deren Herstellung und Arzneimittel die diese Derivate enthalten
FI930603A7 (fi) Aminosubstituoidut bentsoyyliguanidiinit, menetelmät niiden valmistamiseksi, niiden käyttö lääkkeinä samoin kuin niitä sisältävät lääkkeet
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
IT1219811B (it) Derivati peptidici,loro preparazione e loro impiego come medicamenti
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE222897T1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten
DE69517936D1 (de) Substituierte 4-Phenyl-Thiazole Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
IL97784A0 (en) 24-oxa derivatives in the vitamin d series,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3868309D1 (de) Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel.
ATE230731T1 (de) Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten
ATE67210T1 (de) Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
ATE194599T1 (de) Cyclische nitrone, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
HUT77004A (hu) Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
DE69414622D1 (de) Streptogramine in gereinigte Form, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE68902811D1 (de) Pharmazeutische zusammensetzungen mit einem gehalt an labdan-di-terpenoid-derivaten und pyrimido(6,1-a)isochinolin-4-on-derivaten und ihre anwendung.
DE3780438D1 (de) N-substituierte cyclische amine, ihre herstellung sowie pharmazeutische zusammensetzungen die sie enthalten.
FI954982L (fi) Uusia naftyridiinijohdannaisia, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia käytettäväksi erityisesti solujen lisääntymistä estävinä lääkkeinä
DE69307894D1 (de) Ng-monomethyl-l-arginin-hydrochlorid-derivate und verfahren zu deren herstellung
DE69220389D1 (de) Tetrahydroisoquinolinderivate, Verfahren zu deren Herstellung und fungizide Mittel die sie enthalten
DE69221802D1 (de) Thienocyclopentanonoximether, ihre Herstellung und diese enthaltende Arzneimittel
DE69320104D1 (de) Furobenzopyranderivate, Verfahren zu ihrer Herstellung und Herbizide, die diese Derivate als aktive Komponenten enthalten
DE68902789D1 (de) 4-hydroxy-isoxazol-derivate, deren herstellung und kosmetische und pharmazeutische zusammensetzungen, die sie enthalten.
ATE78253T1 (de) N-substituierte cyclische amine, ihre herstellung sowie pharmazeutische zusammensetzungen die sie enthalten.
FI902119A7 (fi) Tetrahydroisokino(2,1-c)(1,3)bentsodiatsepiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee